DOCSLIB.ORG

Of the Uterine Cervix In-Situ Dysplasia, and Carcinoma

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Of the Uterine Cervix In-Situ Dysplasia, and Carcinoma The Growth Characteristics in Vitro of Normal Epithelium, Dysplasia, and Carcinoma-//?-^/// of the Uterine Cervix* RALPH M. RICHART (Departments of Pathology and Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, and the Obstetrical and Gynecological Service [The Sloane Hospital] of the Presbyterian Hospital, New York, N.Y.) SUMMARY Normal cervical epithelium and epithelium containing only dysplasia and carcinoma- in-situ have been grown in vitro as "pure" cell types without contamination by fibro- blasts or squamous epithelium of a significantly different histological type. Excel lent growth was obtained from all types of tissues explanted, and the morphology and pattern of growth were compared. Individual differences in growth pattern between the different cases of dysplasia and curcinoma-in-situ were noted. These were dis tinctive enough so that the cases could be consistently identified by their morphology without reference to identifying labels. No striking differences in growth rates were noted among the three epithelia, and, although there were remarkable differences in cellular behavior and morphology between the normal and abnormal epithelia, no striking differences were observed between dysplasia and earcinoma-m-sííw. Numerous authors have reported on the growth of nor saline, a drawing of the distribution of toluidin blue-posi mal cervical epithelium and intraepithelial and invasive tive epithelium is consulted and a biopsy taken, the limits carcinoma in vitro. Considerable variation in success rate of which are contained within the area of iutraepithelial in growing the various types of epithelium has been re neoplasia. This biopsy is placed in a wash solution and ported, and, as well, there has been variability in the taken immediately to the laboratory. It is then split observations made on the outgrowths. The reported longitudinally, one-half retained for histology and the variability may be at least partially accounted for by the other half prepared for tissue culture. A plane is devel difficulty in maintaining rigorous control over the type of oped between the epithelium and the stroma, and the epithelium that is placed in vitro. This paper reports a stroma is stripped away and retained for histological exam series of in vitro observations on normal cervical epithe ination. The stripped epithelium is finely minced, and the lium, dysplasia, and carcinoma-m-stïwin which the type of fragments are placed under perforated cellophane in a epithelium grown in culture was precisely known and special circular micro-glass culture chamber. The cultures rigidly controlled. are incubated in a humidified C02 incubator and are fed routinely 3 times a week. When sufficient outgrowth is MATERIALS AND METHODS obtained the cells are harvested with a solution of 0.25 per The detailed methods used in this study have been de cent trypsin and 0.2 per cent sodium versenate in a bal scribed previously (12) but are summarized in the following anced salt solution, and are replated. paragraphs. According to these procedures 52 biopsies have been Patients are chosen on the basis of abnormal cytologie placed in vitro, including four biopsies of normal epithe examinations based on the differential cell counting tech- lium, eight of carcmoina-in-situ, and 40 of mild, moderate, nic (8, 9). They are examined colpomicroscopically to and severe dysplasia. determine the type of epithelium present on the exposed portion of the cervix (7), after which the distribution of RESULTS toluidin blue-positive epithelium is noted (10), and, if the Fifteen of the biopsies were grown in Puck's F4-FC area of intraepithelial neoplasia is large enough so that one media and 37 in Eagle's minimal essential media with 15 or more biopsies may be taken that will include only blue- per cent fetal calf serum. Growth was obtained in all the staining epithelium, the patient is chosen for study. At biopsies in Puck's media, but it was impossible to maintain the next visit the cervix is thoroughly washed with sterile the culture or to sub-culture by this media. The discus sion of results will be confined to the 37 biopsies which «Aided by USPHS grants: C-9800, GM-K3-13975, RG-8165, were grown with Eagle's. In 27 of these biopsies excellent and a General Research Support Grant from the National Insti tutes of Health. growth was obtained. In 22 the outgrowth was composed Received for publication September 27, 1963. of epithelial cells alone, whereas in five there was fibro- 002 Downloaded from cancerres.aacrjournals.org on September 28, 2021. © 1964 American Association for Cancer Research. RicHART—Carcinoma-m-siiu. of Uterine Cervix 663 blastic contamination. One culture was contaminated by DISCUSSION fungi within the first 3 days after culture, and one of the In a recent paper Mellgren et al. (3) studied the growth plates containing good growth became contaminated after rate of normal epithelium, dysplasia, and carcinoma-in-situ several weeks in culture. In nine biopsies there was no as well as invasive carcinoma. They found that, although growth, but two of these occurred as a result of an incuba invasive carcinoma had a higher mean growth rate than tor accident. did other forms of cervical epithelium, there was no differ The first outgrowth was observed in all types of epithe ence between the growth rate of dysplasia or carcinoma-m- lium between the 4th and 7th days, the great majority situ and normal epithelium from the same patients. This occurring at 6 days after explantation. The normal epithe observation is in keeping with our findings. Moore, in lium characteristically grew out as a confluent monolayer two papers (4, 5), has described growth characteristics of composed of a mosaic of uniform cells (Figs. 1, 2, 3). The normal cervical epithelium, carcinoma-zn-si/M and invasive most striking feature of the outgrowth was that it was a carcinoma with roller tubes and the Maximow double confluent sheet, each cell border being intimately juxta coverslip technic. He has described one case of carci- posed to the neighboring cells. The only place a free noma-in-situ which was cultured on two different occasions border was found was at the growing edge of the sheet. with good growth each time, in which the cell type was Mitoses were frequent, and the growth, as estimated from said to be of a uniform pattern, well differentiated with an the number of mitotic figures observed, was sustained at a extensive, regular mosaic of cells. This description sug relatively constant rate which did not appear to differ strikingly from that of dysplasia or carcinoma-m-siiw. gests that the observations were made on portions of nor mal epithelium, and Moore has alluded to this possibility After approximately 1 week in culture, scattered areas in by stating that the tissue placed in culture "may not in the normal epithelium began to change in their morphology clude a sample of the specific area desired for study." and to be composed of larger and flatter cells with small Grand (2) noted differences between normal epithelium, centrally placed nuclei (Fig. 4). These cells were not un dysplasia, carcinoma-in-s¿¿w,and invasive carcinoma, like the cells of superficial cervical epithelium, and in the particularly related to the time after explantation in which areas in which this change occurred no further mitotic activity was noted. outgrowth occurred and in the growth rate. He reported In the dysplasia and carcinoma-m-s#u group virtually that the time for outgrowth to occur decreased progres sively and the growth rate increased progressively as one every case had a separate and distinctive morphology (Figs. 5-13). The differences in growth pattern resulted passed from normal epithelium through dysplasia and carcinoma-m-sîiwto invasive carcinoma. This is at primarily from variations in the degree of cell cohesion, variance with our results. The author does not state how differences in the numbers of cell processes which were the biopsy sites were chosen, nor are there any photographs extended, and differences in propensity toward migration. illustrating either the types of epithelium placed in vitro or In the latter instance cells in the cultures maintained the pattern of the growth. Zinser (13) in cover-glass different degrees of dispersion at the periphery of the cultures compared normal cervical epithelium with inva colonies, and in some cases isolated cells migrated for con sive carcinoma and carcinoma-m-stÕMand found that siderable distances away from the main areas of growth. differences in growth activities were appreciable only be It has not been possible to predict the pattern of growth tween normal and abnormal epithelium on the one side and thefrom dysplasias the histology and of carcinomas-in-sz'fw the explanted epithelium. exhibit a Most striking of carcinoma and carcinoma-¿n-s¿íwonthe other. Glatthaar (1) could find no growth whatsoever in normal epithelium degree of lack of cell contact which results in a more dis or "agitated and abnormal epithelium," but says this persed culture in which numerous cell processes are seen, tissue could be kept alive and could be studied by phase- giving these cells an irregular outline. contrast microscopy and stated, "the cells are the very Because of the unique morphology of each individual same we find in vaginal smears." culture one quickly learns the morphological characteristics It seems to be agreed that normal cervical epithelium is of each and can distinguish among a small group of them technically more difficult to grow in vitro than are the ab consistently, without referring to identifying numbers on normal epithelia. Although Glatthaar was unable to the culture plate, by noting the growth pattern and cellular grow normal epithelium and Moore and Grand both men morphology.
Load more

Recommended publications
  • Pathologic and Molecular Aspects of Anaplasia in Circumscribed Gliomas and Glioneuronal Tumors
    Brain Tumor Pathology (2019) 36:40–51 https://doi.org/10.1007/s10014-019-00336-z REVIEW ARTICLE Pathologic and molecular aspects of anaplasia in circumscribed gliomas and glioneuronal tumors Elisabet Pujadas1 · Liam Chen1,2 · Fausto J. Rodriguez1,3 Received: 6 February 2019 / Accepted: 28 February 2019 / Published online: 11 March 2019 © The Japan Society of Brain Tumor Pathology 2019 Abstract Many breakthroughs have been made in the past decade regarding our knowledge of the biological basis of the diffuse glio- mas, the most common primary central nervous system (CNS) tumors. These tumors as a group are aggressive, associated with high mortality, and have a predilection for adults. However, a subset of CNS glial and glioneuronal tumors are char- acterized by a more circumscribed pattern of growth and occur more commonly in children and young adults. They tend to be indolent, but our understanding of anaplastic changes in these tumors continues to improve as diagnostic classifications evolve in the era of molecular pathology and more integrated and easily accessible clinical databases. The presence of ana- plasia in pleomorphic xanthoastrocytomas and gangliogliomas is assigned a WHO grade III under the current classification, while the significance of anaplasia in pilocytic astrocytomas remains controversial. Recent data highlight the association of the latter with aggressive clinical behavior, as well as the presence of molecular genetic features of both pilocytic and dif- fuse gliomas, with the recognition that the precise terminology remains to be defined. We review the current concepts and advances regarding histopathology and molecular understanding of pilocytic astrocytomas, pleomorphic xanthoastrocytomas, and gangliogliomas, with a focus on their anaplastic counterparts.
    [Show full text]
  • SOMATIC MUTATIONS AS a FACTOR in the PRODUC- TION of CANCER for Nearly Thirty Years the Phenomenon Known by Von Hanse- Mann's
    SOMATIC MUTATIONS AS A FACTOR IN THE PRODUC- TION OF CANCER A CRITICAL REVIEW OF v. HANSEMANN’S THEORY OF ANAPLASIA IN THE LIGHT OF MODERN KNOWLEDGE OF GENETICS R. C. WHITMAN From the Henry S. Denison Research Laboratories of the University of Colorado, Received for publication, March 4, 1918 For nearly thirty years the phenomenon known by von Hanse- mann’s term, anaplasia, has been widely used among patholog- ists to describe and exphin the origin of cancer cells. Any well established facts, therefore, which throw added light upon the nature of the process of anaplasia itself and any possible relation it may have to cancer genesis must be important and significant. The term anaplasia has been, however, so loosely used that it will be worth while to review at length von Hansemann’s theory in order that we may start with a clear conception of what the word really means. The pleomorphism of cancer cells and the irregular, atypical mitoses so characteristic of their nuclei had been observed and carefully studied since the middle of the nine- teenth century. Arnold (Virch. Arch., vol. 79, cited by von Hansemann (l)),observing irregularities in the mitotic process itself, had inferred that thesemight be of fundamental significance. A voluminous literature dealing with the mitoses in cancer cells and other forms of rapidly proliferating tissues had already ac- cumulated when von Hansemann (1) undertook a further inves- tigation in the same field. In a carcinoma of the larynx he found besides a great abundance of normal mitotic figures, large numbers of tripolar and multipolar divisions and other departures from the normal type already observed and described by earlier writers; and in addition many hyperchromatic and hypochromatic mitoses, the hypochromatism consisting not merely in a reduction of the amount of chromatin in the chromosoines but rather in an 181 182 R.
    [Show full text]
  • Nodal Metastases from Laryngeal Carcinoma and Their Correlation with Certain Characteristics of the Primary Tumor
    NODAL METASTASES FROM LARYNGEAL CARCINOMA AND THEIR CORRELATION WITH CERTAIN CHARACTERISTICS OF THE PRIMARY TUMOR Kamaljit Kaur ~, Nishi Sonkhya 2, A.S. Bapna 3 Key Words : Carcinoma larynx, nodal metastases. INTRODUCTION nodal metastases progresses in an orderly manner with Cancer of the larynx represents about 2% of the total the first site of metastasis being the sentinel node. cancer risk and is the most common head and neck cancer (skin excluded). It has been consistently observed by Lymphatic metastasis is the most important mechanism various authors that the status of cervical lymph nodes is in the spread of head and neck squamous cell carcinoma. the single most important prognostic factor in laryngeal Multiple clinical studies have demonstrated that the carcinoma and the probability of 5 year survival, regardless distribution of cervical lymph node metastases is indeed of the treatment rendered, reduces by 50% once the tumor predictable in patients with previously untreated squamous dissemination to the regional lymph nodes has taken place. cell carcinoma of the upper aerodigestive tract. The rate For this reason, studies dealing with the probability of of metastasis probably reflects the aggressiveness of the nodal metastases are important in making therapeutic primary tumor and is an important prognosticator. Not decisions. only the presence, but also the number of nodal metastases, their level in the neck, the size of the nodes and the presence Although the credit for first injection studies of laryngeal of extra-capsular spread are important prognostic feature. lymphatics goes to Hajek in 1891, it was the monumental study of laryngeal lymphatics by injections of dyes and There is a need to identify pretreatment factors that can radioisotopes by Pressman et al in 1956 that provided differentiate high risk from low risk patients with respect excellent documentation of the anatomical to occult metastases.
    [Show full text]
  • VARYING DEGREES of MALIGNANCY in CANCER of the BREAST Differences in the Degree of Malignancy of Malignant Tumors Have Been Reco
    VARYING DEGREES OF MALIGNANCY IN CANCER OF THE BREAST ROBERT 13. GREENOUGH BOSTON Differences in the degree of malignancy of malignant tumors have been recognized by pathologists for many years. Indeed, Virchow’s original conception of a malignant tumor was one composed of cells, derived from the tissue cells of the individual, but differing from the normal cells in the rapidity and independ- ence of their growth. Hansemann (1) carried this idea somewhat further and intro- duced the word “anaplasia” to indicate the process by which cancer cells came to differ from the normal type cell of the body tissue concerned. Anaplasia involves a loss of differentiation and an increase of reproductive power, so that the anaplastic cell fulfils only in abortive fashion, if at all, its normal function, such as secretion or keratinization; while it shows by increased number of mitotic figures, and especially by the irregularity and abnormality of its nuclear chromatic elements and figures, the increase in rapidity of cell division and of cell growth which is characteristic of malignancy. X number of attempts have been made to grade the malig- nancy of different breast tumors by distinguishing their histo- logical characteristics, such as adenocarcinoma, medullary, scirrhus, colloid, etc. ; but with the exception of adenocarcinoma and colloid, these divisions have proved of little value in prognosis. There the matter rested till 1921, when, under the influence of MacCarty (2) of the Mayo Clinic, Broders published a paper suggesting the classification of cancer tissue according to the degree of malignancy, as estimated by loss of differentiation and increase of reproductive characteristics.
    [Show full text]
  • Histological Typing of Prostate Tumours
    HISTOLOGICAL TYPING OF PROST ATE TUMOURS INTERNATIONAL HISTOLOGICAL CLASSIFICATION OF TUMOURS No. 22 HISTOLOGICAL TYPING OF PROSTATE TUMOURS F. K. MOSTOFI Head, WHO Collaborating Centre for the Histological Classification of Male Urogenital Tract Tumours, Armed Forces Institute of Pathology, Washington, DC, USA '- in collaboration with I. SESTERHENN L. H. SOBIN Armed Forces Institute of Pathologist, Pathology, World Health Organization, Washington, DC, USA Geneva, Switzer/and and pathologists in eight countries WORLD HEALTH ORGANIZATION GENEVA 1980 ISBN 92 4 176022 2 ©World Health Organization 1980 Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. For rights of reproduction or translation of WHO publications, in part or in toto, application should be made to the Office of Publications, World Health Organization, Geneva, Switzerland. The World Health Organi­ zation welcomes such applications. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Director-General of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. Authors alone are responsible for views expressed in this publication.
    [Show full text]
  • Contributions of Mouse Biology to Breast Cancer Research
    Comparative Medicine Vol 52, No 1 Copyright 2002 February 2002 by the American Association for Laboratory Animal Science Pages 12-31 Overview Contributions of Mouse Biology to Breast Cancer Research Table of Contents Introduction (R. D. Cardiff, M.D., Ph.D.) The University of California Origins of Experimental Breast Cancer Research: H. A. Bern, Ph.D. 1) The Mammary Gland-Free Fat Pad Transplantation Systems A) The Gland-Cleared Fat Pad: The Foundation for Mammary Immortality and Preneoplasia: L. J. Faulkin, Ph.D. B) Senescence of Mouse Mammary Epithelial Cells: C. W. Daniel, Ph.D. C) Mammary Epithelial Stem Cells: G. H. Smith, Ph.D. D) Preneoplasia: a. The Hyperplastic Outgrowth (HPO) in Mammary Tumor Biology: L. J. T. Young and D. Medina, P.h.D. b. The Mouse Mammary Tumor Virus and Mammary Tumorigenesis: R. D. Cardiff, M.D., Ph.D. c. Mammary Tumor Viruses in Wild Mice and Humans: M. B. Gardner, M.D. d. Comparative Pathology of the Mammary Gland: S. R. Wellings, M.D., Ph.D. 2) Hormonal Regulation A) Ovarian Hormones in Mammary Growth and Development: G. Shyamala, Ph.D. B) Preventing Breast Cancer with Estrogen: Mimicking the Protective Effect of Pregnancy: R. Guzman, Ph.D., L. Rajikumar, Ph.D., J. Yang, M.D., Ph.D., G. Thordarson Ph.D., and S. Nandi, Ph.D. 3) Genetically Engineered Mice and Neoplastic Progression A) Genetically Engineered Mice: R. D. Cardiff, M.D., Ph.D. B) Premalignancy a. The Preneoplastic Phenotype in the p53 Null Mammary Gland: D. Medina, Ph.D. b. PyV-mT: A New Model for Mammary Premalignancy: C.
    [Show full text]
  • Penile Cancer TOC Discussion
    ® NCCN NCCN Guidelines Index Penile Cancer TOC Discussion NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines® ) Penile Cancer Version 1.2012 NCCN.org Continue Version 1.2012, 04/03/12 © National Comprehensive Cancer Network, Inc. 2012, All rights reserved. The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®. ® NCCN NCCN Guidelines Version 1.2012 Panel Members NCCN Guidelines Index Penile Cancer TOC Penile Cancer Discussion * Peter E. Clark, MD w Chair Timothy M. Kuzel, MD ‡ Michael P. Porter, MD, MS w Vanderbilt-Ingram Cancer Center Robert H. Lurie Comprehensive Cancer Fred Hutchinson Cancer Research Center/ Seattle Center of Northwestern University Cancer Care Alliance * Philippe E. Spiess, MD, MS w Penile Cancer Subcommittee Lead Subodh M. Lele, MD ¹ Jerome P. Richie, MD w H. Lee Moffitt Cancer Center & UNMC Eppley Cancer Center at Dana-Farber/Brigham and Women’s Research Institute The Nebraska Medical Center Cancer Center Neeraj Agarwal, MD ‡ Jeffrey Michalski, MD, MBA § Wade J. Sexton, MD w Huntsman Cancer Institute Siteman Cancer Center at Barnes- H. Lee Moffitt Cancer Center & Research Institute at the University of Utah Jewish Hospital and Washington University School of Medicine William U. Shipley, MD § w * Matthew C. Biagioli, MD, MS § Massachusetts General Hospital Cancer Center H. Lee Moffitt Cancer Center & James E. Montie, MD w Research Institute w University of Michigan Eric J. Small, MD † Comprehensive Cancer Center UCSF Helen Diller Family J. Erik Busby, MD Comprehensive Cancer Center University of Alabama at Birmingham Comprehensive Cancer Center * Lance Pagliaro, MD † The University of Texas Donald L.
    [Show full text]
  • To What Extent Do We Understand DFTD, and What Are the Conservation Options for Tasmanian Devils?
    To what extent do we understand DFTD, and what are the conservation options for Tasmanian Devils? ABIGAIL SHEPPARD CANDIDATE NUMBER: 8972, CENTRE NUMBER: 58625 Table of Contents Abstract ................................................................................................................................................... 3 Glossary ................................................................................................................................................... 3 Introduction ............................................................................................................................................ 5 Literature Review .................................................................................................................................. 6 History of the Tasmanian Devil .......................................................................................................................... 6 What is DFTD? ................................................................................................................................................... 9 Allograft Theories of Transmission ................................................................................................................... 14 Immune Response to DFTD ........................................................................................................................... 16 Genetic Diversity and the MHC ...................................................................................................................
    [Show full text]
  • Mutations of the P53 Tumor Suppressor Gene Occur Infrequently in Wilms' Tumor' David Malkin,2 Elizabeth Sexsmith, Herman Yeger, Bryan It G
    [CANCER RESEARCH54, 2077-2079, April 15, 1994] Advances in Brief Mutations of the p53 Tumor Suppressor Gene Occur Infrequently in Wilms' Tumor' David Malkin,2 Elizabeth Sexsmith, Herman Yeger, Bryan it G. Williams, and Max J. Coppes Division of Hematology/Oncology, Department of Pediatrics fD. M., E. S.], and Department of Pathology [H. }‘j,The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada; Department of Cancer Biology, Research Institute, The Cleveland Clinic Foundation@ Cleveland Ohio 44195 [B. R. G. WJ; and the Pediatric Oncology Program, Alberta Children's Hospita4 Calgary, Alberta, Canada T2T 5C7 (M. J. C.] Abstract ample, nephrogenic rests, foci of persistent embryonal nonmalignant remnants, are demonstrated within the kidneys of approximately 30— Mutations of the p53 tumor suppressor gene occur frequently in a 40% of children with WI' (14). These lesions are apparent precursors variety ofadult-onset tumors, including colon, breast, lung, and brain, yet of WT (15). Wi' is also associated with specific congenital abnormal are infrequently identified In pediatric malignancies. Wilma' tumor, a common solid tumor ofchildhood, can be associated with mutations of the ities, including genitourinary anomalies, sporadic aniridia, mental w'ri gene.Alterationsofthep53genehavebeenshownto modulatethe retardation, and hemihypertrophy (16). Genetic predisposition to WT ability of WT1 to transactivate its targets. Although positive p5.3 immu is recognized in two distinct syndromes with urogenital malforma nostaining has been demonstrated in Wilms' tumors, the correlation to tions (WAGR syndrome and Denys-Drash syndrome), as well as in p53 genemutations is not clear. We examinedWilms' tumor samplesfor BWS, a congenital overgrowth syndrome characterized by growth p53 mutatIons utilizing polymerasechain reaction-single-strandconfor abnormalities and a predisposition to several embryonal neoplasms, mation polymorphism analysis and single-strand DNA sequencing.
    [Show full text]
  • Progression and Regression of Cervical Lesions
    J Clin Pathol 1980;33:517-522 Progression and regression of cervical lesions Review of smears from women followed without initial biopsy or treatment Al SPRIGGS* AND MM BODDINGTONt From the Laboratories of Clinical Cytology, *Churchill Hospital, Oxford, and tRoyal Berks Hospital, Reading, UK SUMMARY Cervical smears were reviewed from patients in whom a cytological abnormality was followed, after an interval without interference, either by regression to 'negative' or else by pro- gression to invasive carcinoma. Twenty-eight cases were from a previously analysed series with positive smears and an interval of at least two years before investigation, resulting from refusal or failure to trace. Slides were also reviewed from 25 cases in which 'positive' smears had regressed to negative without escaping from surveillance, and from 10 patients subsequently developing invasive carcinoma whose previous slides, taken several years earlier, showed abnormalities on review. None of these 63 patients had any biopsy or other surgical procedure to the cervix between the initial smear and the outcome. Slides showing 'superficial cell dyskaryosis' and/or well-differentiated 'parabasal cell dyskaryosis' were found only among the groups with subsequent regression. Those showing dissociated poorly differentiated dyskaryotic parabasal cells regressed to negative in two cases and progressed to invasion in nine. This suggests that many examples of spontaneous regression correspond to mild dysplasias which are not precancerous, and overdiagnosis must often have resulted in unnecessary surgical procedures in the past. 'Regressing' and 'progressing' groups both included cases in which the spatula had removed coherent pieces of undifferentiated epithelium. These are difficult to interpret cytologically. In nine of them (including four which regressed) the cytological picture was that of carcinoma in situ.
    [Show full text]
  • Neoplasia.Pdf
    Neoplasia Mar 14, 2005 Robbins and Cotran Chapter 7 pp. 269-339 Definitions • Neoplasia - new growth – Abnormal mass of tissue with growth that exceeds and is uncoordinated with that of the surrounding normal tissues; autonomous • Tumor - synonymous with neoplasm • Cancer - common term for malignant neoplasm •Neoplasms have parenchyma and stroma • Benign and malignant tumors each have their own nomenclature Benign tumors • Based on parenchymal component • Mesenchymal tumors add -oma to cell of origin – Fibroblasts = fibroma – Cartilage = chondroma – Osteoblasts = osteoma • Epithelial tumors can be named for cell of origin, microscopic architecture, or macroscopic appearance – Adenoma = glandular appearance OR from glandular tissue Malignant tumors • Mesenchymal tumors usually called sarcomas – Fibrosarcoma, liposarcoma, leiomyosarcoma, rhabdomyosarcoma • Epithelial tumors usually called carcinomas – Adenocarcinoma = glandular growth pattern – Squamous cell carcinoma = squamous pattern – Can either be named for organ of origin, or “poorly differentiated” or “undifferentiated” • Many exceptions Liver tumors • Focal nodular hyperplasia - spontaneous • Nodular regenerative hyperplasia - portal hypertension • Hemangiomas - benign blood vessel tumors • Liver cell adenomas - rarely become malignant • Hepatocellular carcinoma (HCC) - common • Cholangiocarcinoma - much less common Biology of tumor growth 1) Malignant change in target cell (transformation) 2) Growth of the transformed cells 3) Local invasion 4) Distant metastases • Generally, morphologic
    [Show full text]
  • Carcinogenesis-Mechanisms-And-Manifestations.Pdf
    Author's personal copy CHAPTER 5 Carcinogenesis: Mechanisms and Manifestations David E. Malarkey1, Mark Hoenerhoff1, Robert R. Maronpot2 1National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA, 2Maronpot Consulting, LLC, Raleigh, North Carolina, USA OUTLINE 1. Introduction 107 2.5. Gene Regulation 127 1.1. Overview 107 2.6. Cancer Stem Cell Theory 129 1.2. Background 109 2.7. Tumor Regression 133 1.3. Initiation, Promotion, and Progression 110 3. Identifying Carcinogens 134 1.4. Preneoplasia 115 3.1. Animal Bioassays 134 1.5. Hypertrophy 116 3.2. Data Evaluation and Interpretation 136 1.6. Metaplasia and Anaplasia (Atypia) 117 3.3. Genotoxic and Non-Genotoxic Carcinogens 139 1.7. Benign vs malignant neoplasms 117 3.4. Risk Assessment 140 2. Cancer is a Genetic Disease 117 3.5. Molecular Epidemiology 141 2.1. Overview 117 4. Conclusions 143 2.2. Oncogenes, Tumor Suppressors, Apoptosis and Repair Genes 120 Acknowledgments 144 2.3. Cell Proliferation and Apoptosis 124 Suggested Reading 144 2.4. Somatic Mutation Theory 125 We foresee cancer research as an increasingly exponentially increased risk for developing logical science, in which complexities are manifesta- cancer. There is a similar window of increased tions of a small set of underlying organizing princi- susceptibility to chemically-induced neoplasms ples. (Hanahan and Weinberg, 2011) in rodents treated with either a single or chronic exposure(s) to carcinogen(s). Identifying poten- 1. INTRODUCTION tial human carcinogens in rodent bioassays has been a major focus of the field of toxicologic 1.1. Overview pathology. It is estimated that 5% of human cancers are Cancer is a major cause of debilitation and caused by viruses, 5% by radiation, and the death in humans and animals.
    [Show full text]